Inflammatory Bowel Disease-Associated Cancers: Does Gender Change Incidence?

Gastroenterology

Volumn 138, Issue 5, 2010, Pages 1658-1660

  Ullman, Thomas A ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESALAZINE; MUCIN; SEX HORMONE;

CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; COLON RESECTION; COLONOSCOPY; COLORECTAL CANCER; DISEASE ASSOCIATION; EDITORIAL; ENTERITIS; GENDER; HIGH RISK PATIENT; HISTOPATHOLOGY; MICROSATELLITE INSTABILITY; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; SEX DIFFERENCE; ULCERATIVE COLITIS;

EID: 77951687699     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2010.03.025     Document Type: Editorial

References (17)

1. Farraye F.A., Odze R.D., Eaden J., et al. AGA technical review on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease. Gastroenterology 138 (2010) 746-774
2. Nuako K.W., Ahlquist D.A., Mahoney D.W., et al. Familial predisposition for colorectal cancer in chronic ulcerative colitis: a case-control study. Gastroenterology 115 (1998) 1079-1083
3. Gupta R.B., Harpaz N., Itzkowitz S., et al. Histologic inflammation is a risk factor for progression to colorectal neoplasia in ulcerative colitis: a cohort study. Gastroenterology 133 (2007) 1099-1105
4. Rutter M., Saunders B., Wilkinson K., et al. Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis. Gastroenterology 126 (2004) 451-459
5. Söderlund S., Granath F., Broström O., et al. Inflammatory bowel disease confers a lower risk of colorectal cancer to females than to males. Gastroenterology 138 (2010) 1697-1703
6. Brenner H., Hoffmeister M., Arndt V., et al. Gender differences in colorectal cancer: implications for age at initiation of screening. Br J Cancer 96 (2007) 828-831
7. Nguyen S.P., Bent S., Chen Y.H., et al. Gender as a Risk factor for advanced neoplasia and colorectal cancer: a systematic review and meta-analysis. Clin Gastroenterol Hepatol (2009 Jan 29) Epub ahead of print
8. Ferlay J., Autier P., Boniol M., et al. Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 18 (2007) 581-592
9. Velayos F.S., Terdiman J.P., and Walsh J.M. Effect of 5-aminosalicylate use on colorectal cancer and dysplasia risk: a systematic review and metaanalysis of observational studies. Am J Gastroenterol 100 (2005) 1345-1353
10. Bernstein C.N., Blanchard J.F., Metge C., et al. Does the use of 5-aminosalicylates in inflammatory bowel disease prevent the development of colorectal cancer?. Am J Gastroenterol 98 (2003) 2784-2788
11. Terdiman J.P., Steinbuch M., Blumentals W.A., et al. 5-Aminosalicylic acid therapy and the risk of colorectal cancer among patients with inflammatory bowel disease. Inflamm Bowel Dis 13 (2007) 367-371
12. Ullman T., Croog V., Harpaz N., et al. Progression to colorectal neoplasia in ulcerative colitis: effect of mesalamine. Clin Gastroenterol Hepatol 6 (2008) 1225-1230
13. Kane S.V., Cohen R.D., Aikens J.E., et al. Prevalence of nonadherence with maintenance mesalamine in quiescent ulcerative colitis. Am J Gastroenterol 96 (2001) 2929-2933
14. Sewitch M.J., Abrahamowicz M., Barkun A., et al. Patient nonadherence to medication in inflammatory bowel disease. Am J Gastroenterol 98 (2003) 1535-1544
15. Karlen P., Kornfeld D., Brostrom O., et al. Is colonoscopic surveillance reducing colorectal cancer mortality in ulcerative colitis? A population based case control study. Gut 42 (1998) 711-714
16. Velayos F.S., Loftus Jr. E.V., Jess T., et al. Predictive and protective factors associated with colorectal cancer in ulcerative colitis: a case-control study. Gastroenterology 130 (2006) 1941-1949
17. Karlen P., Lofberg R., Brostrom O., et al. Increased risk of cancer in ulcerative colitis: a population-based cohort study. Am J Gastroenterol 94 (1999) 1047-1052